decemb
wuhan
health
commiss
report
group
peopl
pneumonia
epidemiolog
link
seafood
live
anim
market
wuhan
china
etiolog
identifi
new
coronaviru
suppos
zoonot
origin
viru
recent
name
coronaviru
sever
acut
respiratori
syndrom
type
diseas
call
coronaviru
diseas
far
uncertainti
regard
transmiss
capac
viru
recent
studi
show
presenc
high
viral
load
oropharynx
earli
stage
diseas
increas
concern
high
risk
infect
incub
period
mild
symptom
averag
incub
period
estim
day
rang
day
case
symptom
diseas
mild
fever
cough
expector
gener
malais
approxim
may
seriou
clinic
manifest
pneumonia
clinic
complic
requir
hospit
admiss
pregnant
women
newborn
elderli
immunocompromis
patient
comorbid
diabet
mellitu
hypertens
cardiovascular
diseas
infect
like
suffer
sever
ill
often
requir
admit
icu
impact
chronic
kidney
diseas
scantili
report
current
mortal
rate
china
case
confirm
lab
similar
spain
data
march
howev
still
prematur
establish
true
mortal
rate
countri
kidney
transplant
recipi
due
statu
immunosuppress
clinic
manifest
treatment
prognosi
pneumonia
may
differ
gener
popul
henc
import
earli
diagnosi
screen
case
infect
suspect
gener
popul
lymphopenia
observ
patient
mani
kidney
transplant
recipi
druginduc
lymphopenia
therefor
find
help
diagnosi
therefor
special
attent
paid
type
immunosuppress
patient
evalu
earli
detect
infect
appropri
diagnost
test
admiss
hospit
case
infect
first
case
pneumonia
kidney
transplant
recipi
publish
recent
clinic
featur
symptom
laboratori
test
chest
ct
scan
similar
nontranspl
patient
publish
relev
report
progress
diseas
renal
transplant
popul
transplant
center
spain
alreadi
case
kidney
transplant
patient
affect
publish
therefor
essenti
collabor
countri
prepar
nation
european
registri
learn
detail
epidemiolog
characterist
infect
patient
solid
organ
transplant
includ
kidney
transplant
knowledg
describ
donorrecipi
transmiss
solid
organ
transplant
howev
relat
virus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
report
transplant
recipi
previou
outbreak
virus
base
experi
previou
coronavirus
known
transplant
recipi
expos
viru
would
becom
infect
high
percentag
case
howev
less
known
risk
donorrecipi
transmiss
possibl
donorderiv
infect
may
influenc
exposur
donor
infect
individu
incub
period
asymptomat
peopl
extent
durat
viremia
viabil
viru
within
specif
blood
organ
compart
would
also
affect
risk
donor
transmiss
therefor
despit
possibl
neg
consequ
temporari
interrupt
kidney
transplant
may
necessari
area
viru
expos
intens
current
epidem
europ
still
earli
stage
although
acquisit
knowledg
increas
rapidli
mani
unknown
commun
gener
particularli
transplant
patient
howev
imper
anticip
potenti
impact
transplant
popul
avoid
seriou
consequ
recommend
may
chang
learn
infect
order
acquir
maximum
knowledg
protect
popul
kidney
transplant
recipi
transplant
center
develop
connect
local
infecti
diseas
specialist
infect
prevent
profession
time
import
awar
local
nation
public
health
polici
report
suspect
case
ministri
health
govern
spain
period
publish
implement
technic
report
time
includ
special
consider
kidney
transplant
patient
spanish
nephrolog
societi
wwwsenefroorg
spanish
transplant
societi
wwwsetrasplanteorg
convey
recommend
measur
prevent
conting
kidney
patient
includ
kidney
transplant
patient
nation
transplant
organ
ont
collabor
transplant
coordin
autonomi
region
advic
studi
group
infect
transplant
patient
immunocompromis
host
gesitra
recommend
preserv
donat
transplant
activ
long
pandem
allow
http
wwwont
carri
univers
screen
donor
potenti
organ
recipi
transplant
program
affect
area
make
casebycas
assess
evalu
conveni
perform
transplant
base
avail
resourc
icuresuscit
area
assess
riskbenefit
expos
immunosuppress
patient
risk
infect
base
number
case
possibl
admiss
ideal
isol
condit
versu
need
transplant
patient
clinic
situat
maintain
adequ
hygien
wash
hand
frequent
soap
water
least
alcoholbas
hand
sanit
least
alcohol
especi
use
bathroom
eat
blow
cough
sneez
direct
contact
sick
peopl
surround
avoid
touch
eye
nose
mouth
wash
hand
clean
hous
surfac
done
regularli
clean
disinfect
frequent
touch
object
surfac
avoid
contact
maintain
distanc
least
two
meter
peopl
respiratori
infect
symptom
fever
cough
gener
sore
muscl
sore
throat
respiratori
difficulti
share
person
belong
lockdown
situat
must
remain
home
except
stipul
except
accord
rule
establish
polit
health
author
phone
kidney
transplant
clinic
referr
center
phone
number
author
health
author
tri
follow
correct
diet
avoid
smoke
alcohol
addit
harm
health
substanc
weaken
immun
system
make
bodi
vulner
infecti
diseas
avoid
share
food
utensil
cutleri
glass
napkin
handkerchief
etc
object
without
clean
properli
recommend
gener
popul
peopl
well
wear
face
mask
protect
respiratori
diseas
includ
today
kidney
transplant
popul
must
compli
recommend
measur
protect
gener
popul
especi
asymptomat
home
howev
respons
physician
recommend
use
mask
individu
basi
mainli
case
patient
goe
health
center
place
agglomer
peopl
show
symptom
infect
wear
mask
prevent
spread
diseas
other
would
advis
author
sick
leav
patient
whose
profess
entail
high
risk
infect
recomend
monitor
kidney
transplant
patient
teleconsult
order
reduc
time
spent
health
center
minim
risk
infect
kidney
transplant
patient
symptom
compat
recommend
contact
transplant
specialist
primari
care
physician
prefer
telephon
indic
clearli
chronic
diseas
type
treatment
take
regularli
depend
symptom
present
recommend
mild
symptom
without
dyspneatachypnea
temperatur
c
kidney
receptor
adequ
function
reserv
patient
ask
contact
phone
phone
number
design
health
author
autonom
commun
diagnost
test
perform
remain
home
monitor
symptom
alarm
sign
telephon
monitor
transplant
team
everi
h
moderatesever
symptom
temperatur
c
fragil
receptor
patient
instruct
go
hospit
emerg
depart
clinic
evalu
current
evid
control
clinic
trial
recommend
specif
treatment
coronaviru
gener
popul
patient
suspect
confirm
covid
absenc
conclus
data
treatment
infect
kidney
transplant
patient
drug
use
date
control
diseas
gener
popul
follow
hydroxychloroquin
usual
use
treatment
malaria
amebiasi
antivir
activ
document
vitro
data
avail
human
favor
result
observ
interfer
receptor
intercellular
traffic
viru
dose
mg
everi
h
first
h
mg
everi
h
total
day
requir
adjust
dialysi
liver
failur
chloroquin
altern
hydroxychloroquin
lower
vitro
activ
hydroxychloroquin
dose
mg
everi
h
lopinavirritonavir
combin
proteas
inhibit
antiretrovir
agent
inhibitor
reduc
dosag
calcineurin
inhibitor
mtor
inhibitor
concomit
use
tacrolimu
caus
sever
increas
immunosuppress
level
far
greater
produc
singl
proteas
inhibitor
use
high
risk
toxic
advis
suspend
administr
anticalcineurin
start
monitor
level
h
littl
evid
support
possibl
effect
infect
ongo
clinic
trial
miracl
look
associ
lopinavir
day
treatment
mer
compar
remdesivir
lopinavirritonavir
advantag
wide
avail
accept
toler
toxic
profil
suggest
use
tripl
therapi
lopinavirritonavirribavirin
dose
mg
comp
po
h
maximum
day
dose
mg
sc
everi
h
day
total
dose
risk
acut
reject
due
induct
alloreact
therefor
use
individu
strictli
evalu
riskbenefit
kidney
transplant
patient
remdesivir
prodrug
nucleotid
analog
potent
activ
vitro
broad
spectrum
viru
rna
viru
marburg
ebola
merscov
respiratori
syncyti
viru
nipah
viru
hendra
viru
mechan
action
base
prematur
termin
viral
rna
transcript
suggest
help
reduc
viral
load
improv
respiratori
paramet
anim
vitro
model
sever
clinic
trial
drug
current
underway
compassion
use
dose
load
dose
first
day
mgiv
follow
mainten
dose
mgiv
per
day
day
day
tocilizumab
human
monoclon
anti
receptor
use
sever
case
take
account
role
togeth
proinflammatori
cytokin
develop
ard
dose
mgkg
maximum
dose
mg
iv
singl
dose
consid
repeat
dose
accord
clinic
respons
interv
least
h
maximum
dose
ascorb
acid
citrisali
multicent
trial
suggest
improv
mortal
ard
howev
evid
support
effect
intraven
immunoglobulin
use
sever
case
indic
efficaci
must
evalu
recommend
dose
gkgday
day
mgkgday
day
treatment
highli
question
evid
use
antibiot
treatment
use
case
bacteri
superinfect
studi
recent
publish
demonstr
synergist
effect
combin
hydroxychloroquin
azithromizin
mg
first
day
follow
mgd
day
given
possibl
drug
interact
recommend
care
review
therapeut
combin
well
start
treatment
kidney
transplant
patient
frequent
receiv
drug
block
reninangiotensinaldosteron
system
current
unclear
role
drug
may
play
patient
diseas
american
societi
cardiolog
recommend
stop
drug
patient
take
kidney
transplant
patient
due
immunosuppress
immun
respons
alter
particularli
tcell
immun
respons
littl
evid
regard
minim
manag
pattern
immunosuppress
especi
kidney
transplant
popul
infect
short
period
time
sinc
appear
limit
accumul
experi
insuffici
publish
scientif
evid
date
one
case
patient
pneumonia
kidney
transplant
recipi
publish
whose
clinic
manifest
similar
popul
carri
kidney
transplant
case
tripl
immunosuppress
therapi
receiv
far
discontinu
prednison
mycophenol
mofetil
mmf
tacrolimu
start
methylprednisolon
dose
mgday
plu
nonspecif
immunoglobulin
patient
fever
remit
fifth
day
discontinu
treatment
moment
tacrolimu
restart
half
dose
although
radiolog
sign
pneumonia
still
persist
resolut
clinic
radiolog
symptom
neg
microbiolog
sampl
occur
two
week
onset
clinic
symptom
previou
dose
tacrolimu
mmf
reintroduc
therefor
given
limit
experi
accumul
high
probabl
torpid
evolut
short
period
time
develop
multiorgan
failur
need
respiratori
support
immunosuppress
strategi
recommend
priori
least
sever
case
kidney
transplant
patient
pneumonia
involv
temporari
interrupt
immunosuppress
start
methylprednisolon
low
dose
mgday
confer
rapid
acquisit
necessari
cellular
immun
control
infect
thu
prevent
vital
complic
lowdos
system
corticosteroid
sever
benefici
effect
due
immunomodulatori
antiinflammatori
vascular
properti
confer
immunolog
protect
renal
allograft
corticoid
produc
inhibit
proinflammatori
cytokin
reduct
white
blood
cell
traffic
mainten
integr
permeabl
endothelium
thu
maintain
homeostasi
control
dysregul
immun
system
less
sever
case
altern
could
withdraw
mmf
reduct
dose
calcineurin
inhibitor
far
studi
support
strategi
given
trophism
viru
lung
tissu
seem
undesir
use
antimtor
drug
least
patient
patholog
lower
respiratori
tract
spanish
group
hospit
de
la
paz
recent
commun
protocol
manag
immunosuppress
treatment
patient
infect
tabl
far
resum
immunosuppress
therapi
clear
either
restart
dose
case
evalu
individu
gener
reason
recommend
resum
calcineurin
inhibitor
half
dose
obtain
first
microbiolog
cultur
neg
neg
pcr
patient
remain
asymptomat
add
progress
mmf
follow
day
need
time
experi
abl
optim
treatment
protocol
immunosuppress
strategi
follow
kidney
transplant
patient
infect
prevent
transmiss
renal
transplant
popul
essenti
compli
gener
recommend
particular
emphasi
measur
selfhygien
discontinu
tacrolimu
mmf
imtor
maintain
prednison
mg
day
first
day
dayof
admiss
patient
improv
fever
need
oxygen
resum
maintain
level
ngml
associ
prednison
mg
day
clinic
situat
improv
persist
fever
requir
oxygen
maintain
prednison
mgday
tacrolimu
start
point
patient
improv
start
alreadi
hydroxychloroquin
decreas
dose
tacrolimu
imtor
entri
due
interact
tacrolimu
imtor
chloroquin
patient
contact
case
confirm
coronaviru
infect
symptom
start
hydroxychloroquin
mg
everi
h
day
reduc
tacrolimu
imtor
dose
day
return
usual
dose
maintain
unchang
rest
immunosuppress
minim
risk
infect
teleconsult
recommend
followup
patient
kidney
transplant
recommend
preserv
donat
transplant
activ
extent
pandem
allow
individu
case
depend
characterist
epidemiolog
situat
health
center
due
high
probabl
torpid
evolut
immunosuppress
strategi
recommend
kidney
transplant
recipi
pneumonia
consist
reduct
ultim
temporari
interrupt
immunosuppress
articl
fund
part
ministri
economi
industri
competit
spain
isciii
fund
european
region
develop
funderdf
retic
redinren
